The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. BioAge Labs Inc shares valued at $531,828 were sold by GOLDSTEIN DOV A MD on Jan 13 ’26. At $19.70 per share, GOLDSTEIN DOV A MD sold 27,000 shares. The insider’s holdings dropped to 22,408 shares worth approximately $0.48 million following the completion of this transaction.
Also, Fortney Kristen sold 233,107 shares, netting a total of over 4,223,036 in proceeds. Following the sale of shares at $18.12 each, the insider now holds 976,949 shares.
Before that, Fortney Kristen had added 233,107 shares to its account. In a trade valued at $4,195,926, the 10% Owner bought BioAge Labs Inc shares for $18.00 each.
As published in a research note from Morgan Stanley on December 05, 2025, BioAge Labs Inc [BIOA] has been rated up from an Underweight to an Equal-weight and the price target has been revised to $12. Analysts at Citigroup upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late October. As of February 28, 2025, William Blair has initiated its “Mkt perform” rating for BIOA. Earlier on December 10, 2024, Morgan Stanley downgraded its rating. Their new recommendation was “an Underweight” for BIOA stock which previously was a “an Overweight”.
Analyzing BIOA Stock Performance
On last trading session, BioAge Labs Inc [NASDAQ: BIOA] plunged -6.15% to $21.51. The stock’s lowest price that day was $21.43, but it reached a high of $24.0 in the same session. During the last five days, there has been a surge of approximately 54.53%. Over the course of the year, BioAge Labs Inc shares have jumped approximately 363.58%.
Support And Resistance Levels for BioAge Labs Inc (BIOA)
RSI (Relative Strength Index) is 75.36 on the 14-day chart, showing overbought technical sentiment.
Is BioAge Labs Inc subject to short interest?
Stocks of BioAge Labs Inc saw a sharp rise in short interest on 2025-12-31 jumping by 93128.0 shares to 0.6 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 0.5 million shares. A jump of 15.62% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.29 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.29.
Which companies own the most shares of BioAge Labs Inc (BIOA)?
In terms of BioAge Labs Inc share price expectations, FactSet research, analysts set an average price target of 12 in the next 12 months, down nearly -47.64% from the previous closing price of $22.92. Analysts anticipate BioAge Labs Inc stock to reach 12 by 2026, with the lowest price target being 12. On December 09, 2024, Jefferies assigned a price target of “a Hold” to the stock and downgraded coverage with a $7.
